Ono Pharmaceutical Co., Ltd.

Works in Dermatology · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Psychiatry · Renal & urogenital · Respiratory · Women's health

Ono Pharmaceutical Co., Ltd. is a clinical trial sponsor. It has 35 active clinical trials with 4,387 planned participants, across 14 therapeutic areas. Since 2021 it has completed 32 trials and stopped 4 early.

Trial track record · since 2021

35Active trials4,387 planned participants
32Completed6 with results posted
4Stopped early11% of finished trials

Pipeline · 35 active trials

StageTrialStatus

Questions about Ono Pharmaceutical Co., Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-29.

Approve Suite is not affiliated with Ono Pharmaceutical Co., Ltd..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.